257 related articles for article (PubMed ID: 9689049)
1. Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium.
Goldgur Y; Dyda F; Hickman AB; Jenkins TM; Craigie R; Davies DR
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9150-4. PubMed ID: 9689049
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases.
Maignan S; Guilloteau JP; Zhou-Liu Q; Clément-Mella C; Mikol V
J Mol Biol; 1998 Sep; 282(2):359-68. PubMed ID: 9735293
[TBL] [Abstract][Full Text] [Related]
3. X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform.
Chen Z; Yan Y; Munshi S; Li Y; Zugay-Murphy J; Xu B; Witmer M; Felock P; Wolfe A; Sardana V; Emini EA; Hazuda D; Kuo LC
J Mol Biol; 2000 Feb; 296(2):521-33. PubMed ID: 10669606
[TBL] [Abstract][Full Text] [Related]
4. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design.
Goldgur Y; Craigie R; Cohen GH; Fujiwara T; Yoshinaga T; Fujishita T; Sugimoto H; Endo T; Murai H; Davies DR
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13040-3. PubMed ID: 10557269
[TBL] [Abstract][Full Text] [Related]
5. The catalytic domain of human immunodeficiency virus integrase: ordered active site in the F185H mutant.
Bujacz G; Alexandratos J; Qing ZL; Clément-Mella C; Wlodawer A
FEBS Lett; 1996 Dec; 398(2-3):175-8. PubMed ID: 8977101
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 integrase: the next target for AIDS therapy?
d'Angelo J; Mouscadet JF; Desmaële D; Zouhiri F; Leh H
Pathol Biol (Paris); 2001 Apr; 49(3):237-46. PubMed ID: 11367559
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of catalytic core domains of retroviral integrases and role of divalent cations in enzymatic activity.
Wlodawer A
Adv Virus Res; 1999; 52():335-50. PubMed ID: 10384241
[TBL] [Abstract][Full Text] [Related]
8. Similarities in the HIV-1 and ASV integrase active sites upon metal cofactor binding.
Lins RD; Straatsma TP; Briggs JM
Biopolymers; 2000 Apr; 53(4):308-15. PubMed ID: 10685051
[TBL] [Abstract][Full Text] [Related]
9. Communications: Electron polarization critically stabilizes the Mg2+ complex in the catalytic core domain of HIV-1 integrase.
Lu Y; Mei Y; Zhang JZ; Zhang D
J Chem Phys; 2010 Apr; 132(13):131101. PubMed ID: 20387913
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding.
Chen JC; Krucinski J; Miercke LJ; Finer-Moore JS; Tang AH; Leavitt AD; Stroud RM
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8233-8. PubMed ID: 10890912
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site.
Wielens J; Headey SJ; Jeevarajah D; Rhodes DI; Deadman J; Chalmers DK; Scanlon MJ; Parker MW
FEBS Lett; 2010 Apr; 584(8):1455-62. PubMed ID: 20227411
[TBL] [Abstract][Full Text] [Related]
12. Binding aspects of baicalein to HIV-1 integrase.
Ahn HC; Lee SY; Kim JW; Son WS; Shin CG; Lee BJ
Mol Cells; 2001 Aug; 12(1):127-30. PubMed ID: 11561722
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics studies on the HIV-1 integrase catalytic domain.
Lins RD; Briggs JM; Straatsma TP; Carlson HA; Greenwald J; Choe S; McCammon JA
Biophys J; 1999 Jun; 76(6):2999-3011. PubMed ID: 10354426
[TBL] [Abstract][Full Text] [Related]
14. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity.
Greenwald J; Le V; Butler SL; Bushman FD; Choe S
Biochemistry; 1999 Jul; 38(28):8892-8. PubMed ID: 10413462
[TBL] [Abstract][Full Text] [Related]
15. Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors.
Chen X; Tsiang M; Yu F; Hung M; Jones GS; Zeynalzadegan A; Qi X; Jin H; Kim CU; Swaminathan S; Chen JM
J Mol Biol; 2008 Jul; 380(3):504-19. PubMed ID: 18565342
[TBL] [Abstract][Full Text] [Related]
16. Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein.
Wang JY; Ling H; Yang W; Craigie R
EMBO J; 2001 Dec; 20(24):7333-43. PubMed ID: 11743009
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of the integrase-DNA complex by Mg2+ ions and prediction of key residues for binding HIV-1 integrase inhibitors.
Miri L; Bouvier G; Kettani A; Mikou A; Wakrim L; Nilges M; Malliavin TE
Proteins; 2014 Mar; 82(3):466-78. PubMed ID: 24038133
[TBL] [Abstract][Full Text] [Related]
18. Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: implication for binding to two metal ions on the active site of integrase.
Long YQ; Jiang XH; Dayam R; Sanchez T; Shoemaker R; Sei S; Neamati N
J Med Chem; 2004 May; 47(10):2561-73. PubMed ID: 15115398
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase.
Yang ZN; Mueser TC; Bushman FD; Hyde CC
J Mol Biol; 2000 Feb; 296(2):535-48. PubMed ID: 10669607
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and random mutagenesis analysis of the region carrying the catalytic E152 amino acid of HIV-1 integrase.
Calmels C; de Soultrait VR; Caumont A; Desjobert C; Faure A; Fournier M; Tarrago-Litvak L; Parissi V
Nucleic Acids Res; 2004; 32(4):1527-38. PubMed ID: 14999095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
